Beata Olejnicka

809 total citations
27 papers, 622 citations indexed

About

Beata Olejnicka is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Beata Olejnicka has authored 27 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Beata Olejnicka's work include Protease and Inhibitor Mechanisms (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Calcium signaling and nucleotide metabolism (5 papers). Beata Olejnicka is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Calcium signaling and nucleotide metabolism (5 papers). Beata Olejnicka collaborates with scholars based in Sweden, Germany and Spain. Beata Olejnicka's co-authors include Ulf T. Brunk, Tobias Welte, Min Lü, Georg Ostermann, Andreas Schröder, Tobias Weber, Nina Gellert, Anne Nègre‐Salvayre, Martin Štícha and Christian Weber and has published in prestigious journals such as The FASEB Journal, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Beata Olejnicka

25 papers receiving 614 citations

Peers

Countries citing papers authored by Beata Olejnicka

Since Specialization

Citations

This map shows the geographic impact of Beata Olejnicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beata Olejnicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beata Olejnicka more than expected).

Fields of papers citing papers by Beata Olejnicka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beata Olejnicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beata Olejnicka. The network helps show where Beata Olejnicka may publish in the future.

Co-authorship network of co-authors of Beata Olejnicka

This figure shows the co-authorship network connecting the top 25 collaborators of Beata Olejnicka. A scholar is included among the top collaborators of Beata Olejnicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beata Olejnicka. Beata Olejnicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neutrophil Plasticity in Airway Disease: Balancing Damage and Repair 2025 ·Journal of Innate Immunity ·Sabina Janciauskiene, (unknown), Beata Olejnicka, Sabine Wrenger	0
2	Diagnostic and therapeutic value of human serpin family proteins 2024 ·Biomedicine & Pharmacotherapy ·Sabina Janciauskiene, Urszula Lechowicz, (unknown), Beata Olejnicka, Joanna Chorostowska‐Wynimko	9
3	Plasma levels of α₁-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients 2023 ·ERJ Open Research ·Friedemann Börner, Urszula Lechowicz, Sabine Wrenger, Beatriz Martı́nez-Delgado, Beata Olejnicka, Tobias Welte, Joanna Chorostowska‐Wynimko, Michael Kiehntopf, Sabina Janciauskiene	1
4	Human PBMCs Form Lipid Droplets in Response to Spike Proteins 2023 ·Microorganisms ·(unknown), Paco Pino, (unknown), (unknown), (unknown), (unknown), Julia Held, Sabine Wrenger, Tobias Welte, Florian Μ. Wurm, Beata Olejnicka, Sabina Janciauskiene	1
5	Beneficial effects of alpha-1 antitrypsin therapy in a mouse model of colitis-associated colon cancer 2023 ·BMC Cancer ·Mariam Al-Omari, (unknown), (unknown), (unknown), Beata Olejnicka, Sabina Janciauskiene	4
6	Plasma markers of COVID-19 severity: a pilot study 2022 ·Respiratory Research ·(unknown), Sabina Janciauskiene, Sabine Wrenger, Sonja Volland, (unknown), Jan Fuge, Beata Olejnicka, Isabell Pink, Thomas Illig, (unknown), (unknown), Falk F. R. Buettner, Tobias Welte	16
7	The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients 2022 ·Biomolecules ·(unknown), Malin Fromme, Beata Olejnicka, Tobias Welte, Pavel Strnad, Sabina Janciauskiene, Jan Stolk	11
8	Indirect effect of alpha-1-antitrypsin on endotoxin-induced IL-1β secretion from human PBMCs 2022 ·Frontiers in Pharmacology ·Sabina Janciauskiene, (unknown), Nils Helge Schebb, Falk F. R. Buettner, (unknown), (unknown), Stephan Immenschuh, Veronika Grau, Tobias Welte, Beata Olejnicka	3
9	Oxidative Stress Attenuates TLR3 Responsiveness and Impairs Anti-viral Mechanisms in Bronchial Epithelial Cells From COPD and Asthma Patients 2019 ·Frontiers in Immunology ·Mandy Menzel, Sangeetha Ramu, Jenny Calvén, Beata Olejnicka, Asger Sverrild, Celeste Porsbjerg, Ellen Tufvesson, Leif Bjermer, Hamid Akbarshahi, Lena Uller	31
10	The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions 2018 ·Frontiers in Pharmacology ·Sabina Janciauskiene, Sabine Wrenger, Stephan Immenschuh, Beata Olejnicka, Timm Greulich, Tobias Welte, Joanna Chorostowska‐Wynimko	105
11	Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function 2017 ·International Journal of COPD ·Benjamin Waschki, Henrik Watz, Olaf Holz, H Magnussen, Beata Olejnicka, Tobias Welte, Klaus F. Rabe, Sabina Janciauskiene	27
12	Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency 2017 ·International Journal of COPD ·Cristina Esquinas, Sabina Janciauskiene, (unknown), (unknown), Beata Olejnicka, (unknown), Míriam Barrecheguren, Esther Rodríguez, Alexa Núñez, Francisco Rodríguez‐Frias, Marc Miravitlles	21
13	Symptoms and quality of life in patients with chronic obstructive pulmonary disease treated with aclidinium in a real-life setting 2016 ·European Clinical Respiratory Journal ·Peter Lange, Nina Godtfredsen, Beata Olejnicka, (unknown), Dan Curiac, Sjur Humerfelt, Gunilla Telg, (unknown), (unknown), Elisabeth Wreford Andersen, Leif Bjermer	4
14	Allergen-Specific Immunotherapy Increases Plasma Gelsolin Levels 2014 ·American Journal of Rhinology and Allergy ·Sabina Janciauskiene, Beata Olejnicka, Andreas Rembert Koczulla, Lars‐Olaf Cardell, Tobias Welte, Ulla Westin	3
15	Human Islets in Mixed Islet Grafts Protect Mouse Pancreatic β‐Cells from Alloxan Toxicity 1999 ·Pharmacology & Toxicology ·Björn Tyrberg, Décio L. Eizirik, Stefan L. Marklund, Beata Olejnicka, Ole Madsen, Arne Andersson	6
16	Minute oxidative stress is sufficient to induce apoptotic death of NIT‐1 insulinoma cells 1999 ·Apmis ·Beata Olejnicka, Helge Dalen, Ulf T. Brunk	21
17	A short exposure to a high‐glucose milieu stabilizes the acidic vacuolar apparatus of insulinoma cells in culture to ensuing oxidative stress 1997 ·Apmis ·Beata Olejnicka, Karin Öllinger, Ulf T. Brunk	22
18	Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report 1997 ·British Journal of Cancer ·Henrik Hellquist, Beata Olejnicka, (unknown), (unknown), Christer Sederholm	25
19	Starvation-induced autophagocytosis paradoxically decreases the susceptibility to oxidative stress of the extremely oxidative stress-sensitive NIT insulinoma cells 1997 ·Redox Report ·Beata Olejnicka, Helge Dalen, Marcin Baranowski, Ulf T. Brunk	11
20	Starvation-induced autophagocytosis enhances the susceptibility of insulinoma cells to oxidative stress 1996 ·Redox Report ·(unknown), Beata Olejnicka, Karin Öllinger, Ulf T. Brunk	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact